1-5 of 5
Massimo Menga
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study

Clinical Trials & Observations Brief Report
Anne Ségolène Cottereau, Annibale Versari, Stefano Luminari, Jehan Dupuis, Loïc Chartier, René-Olivier Casasnovas, Alina Berriolo-Riedinger, Massimo Menga, Corinne Haioun, Hervé Tilly, Vittoria Tarantino, Massimo Federico, Gilles Salles, Judith Trotman, Michel Meignan
Journal: Blood
Blood (2018) 131 (22): 2449–2453.
https://doi.org/10.1182/blood-2017-11-816298
Published: 2018
Includes: Supplemental data
Journal Articles

The Presence of FDG PET/CT Focal, Not Osteolytic, Lesion(s) Identifies a Sub-Group of Patients with Smoldering Multiple Myeloma with High-Risk of Progression into Symptomatic Disease

Elena Zamagni, MD, Cristina Nanni, MD, Francesca Gay, MD, Annalisa Pezzi, Statistician, Marilena Bellò, MD, Ilaria Rambaldi, MD, Paola Tacchetti, MD, Annamaria Brioli, MD, Lucia Pantani, MD, Valeria Magarotto, MD, Beatrice Anna Zannetti, MD, Massimo Menga, MD, Giulia Marzocchi, PhD, Carolina Terragna, PhD, Katia Mancuso, MD, Antonio Palumbo, MD, Stefano Fanti, MD, Michele Cavo, MD
Journal: Blood
Blood (2014) 124 (21): 3371.
https://doi.org/10.1182/blood.V124.21.3371.3371
Published: 2014
Journal Articles

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Clinical Trials & Observations
Patrizia Pregno, Annalisa Chiappella, Marilena Bellò, Barbara Botto, Simone Ferrero, Silvia Franceschetti, Francesca Giunta, Marco Ladetto, Giorgio Limerutti, Massimo Menga, Maura Nicolosi, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Luca Vaggelli, Roberto Passera, Gianni Bisi, Umberto Vitolo
Journal: Blood
Blood (2012) 119 (9): 2066–2073.
https://doi.org/10.1182/blood-2011-06-359943
Published: 2012
Journal Articles

The Outcome of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab-CHOP (R-CHOP) Is Not Predicted by 18-FDG-Positron Emission Tomography/Computerized Tomography (PET) Performed at Intermediate In-Course Evaluation, but Only by PET Assessed at the End of Therapy.

Umberto Vitolo, Annalisa Chiappella, Marilena Bellò, Roberto Passera, Barbara Botto, Giancarlo Castellano, Chiara Ciochetto, Simone Ferrero, Chiara Frairia, Silvia Franceschetti, Francesca Giunta, Marco Ladetto, Massimo Menga, Maura Nicolosi, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Luca Vaggelli, Patrizia Pregno, Gianni Bisi
Journal: Blood
Blood (2010) 116 (21): 2819.
https://doi.org/10.1182/blood.V116.21.2819.2819
Published: 2010
Journal Articles

Interim 18-FDG-Positron Emission Tomography/Computed Tomography (PET) Failed to Predict Different Outcome in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab-CHOP.

Patrizia Pregno, Annalisa Chiappella, Marilena Bellò, Roberto Passera, Simone Ferrero, Giulia Benevolo, Carola Boccomini, Giancarlo Castellano, Silvia Franceschetti, Massimo Menga, Lorella Orsucci, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Marco Ladetto, Umberto Vitolo
Journal: Blood
Blood (2009) 114 (22): 99.
https://doi.org/10.1182/blood.V114.22.99.99
Published: 2009